|
SN-NJ-R057
N/A |
|
Monoclonal antibody nanoparticle composite hydrogel containing IL-2 receptor
|
￥Member visible
|
|
|
SN-NJ-R058
N/A |
|
Containing rapamycin-RNA nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R059
N/A |
|
Promoting presentation of liposome vaccine composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R060
N/A |
|
Liposome-containing immune-enhancing composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R061
N/A |
|
Antigen-carrying vesicle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R062
N/A |
|
Antigen-loaded multivesicular liposome composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R064
N/A |
|
Injectable hydrogel
|
￥Member visible
|
|
|
SN-NJ-R063
N/A |
|
Vaccine-containing liposome composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R065
N/A |
|
Biodegradable hydrogel
|
￥Member visible
|
|
|
SN-NJ-R066
N/A |
|
Controlled release sustained release hydrogel
|
￥Member visible
|
|
|
SN-NJ-R067
N/A |
|
Hyaluronic acid hydrogel
|
￥Member visible
|
|
|
SN-NJ-R068
N/A |
|
Adhesion regulator carrier composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R069
N/A |
|
Nucleus targeted delivery carrier composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R070
N/A |
|
Immunoregulatory factor microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R071
N/A |
|
Curcumin microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R072
N/A |
|
Melatonin microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R073
N/A |
|
Tanshinone controlled release microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R074
N/A |
|
Compound hydrogel containing camptothecin microspheres
|
￥Member visible
|
|
|
SN-NJ-R075
N/A |
|
Paclitaxel-loaded PLGA microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R076
N/A |
|
HER2 antibody microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R077
N/A |
|
EGFR antibody microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R077
N/A |
|
EGFR antibody microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R078
N/A |
|
Compound hydrogel containing cytuximab microspheres
|
￥Member visible
|
|
|
SN-NJ-R079
N/A |
|
Herceptin monoclonal antibody microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R080
N/A |
|
Berberine microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R081
N/A |
|
Rituxanumab microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R082
N/A |
|
Muromonab-CD3 microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R083
N/A |
|
Anti-CD3 monoclonal antibody microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R084
N/A |
|
PD-L1 monoclonal antibody microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R085
N/A |
|
Compound hydrogel containing trastuzumab microspheres
|
￥Member visible
|
|
|
SN-NJ-R086
N/A |
|
Composite hydrogel containing Trastuzumab microspheres
|
￥Member visible
|
|
|
SN-NJ-R087
N/A |
|
Pertuzumab composite hydrogel
|
￥Member visible
|
